Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Mol Cell Biochem
2015 Dec 01;4101-2:143-54. doi: 10.1007/s11010-015-2546-4.
Show Gene links
Show Anatomy links
Holothurian glycosaminoglycan inhibits metastasis via inhibition of P-selectin in B16F10 melanoma cells.
Yue Z
,
Wang A
,
Zhu Z
,
Tao L
,
Li Y
,
Zhou L
,
Chen W
,
Lu Y
.
Abstract
P-selectin-mediated tumor cell adhesion to platelets is a well-established stage in the process of tumor metastasis. Through computerized structural analysis, we found a marine-derived polysaccharide, holothurian glycosaminoglycan (hGAG), behaved as a ligand-competitive inhibitor of P-selectin, indicating its potential to disrupt the binding of P-selectin to cell surface receptor and activation of downstream regulators of tumor cell migration. Our experimental data demonstrated that hGAG significantly inhibited P-selectin-mediated adhesion of tumor cells to platelets and tumor cell migration in vitro and reduced subsequent pulmonary metastasis in vivo. Furthermore, abrogation of the P-selectin-mediated adhesion of tumor cells led to down-regulation of protein levels of integrins, FAK and MMP-2/9 in B16F10 cells, which is a crucial molecular mechanism of hGAG to inhibit tumor metastasis. In conclusion, hGAG has emerged as a novel anti-cancer agent via blocking P-selectin-mediated malignant events of tumor metastasis.
Bambace,
The platelet contribution to cancer progression.
2011, Pubmed
Bambace,
The platelet contribution to cancer progression.
2011,
Pubmed
Barkalow,
Dimerization of P-selectin in platelets and endothelial cells.
2000,
Pubmed
Bendas,
Cancer cell adhesion and metastasis: selectins, integrins, and the inhibitory potential of heparins.
2012,
Pubmed
Borsig,
Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis.
2002,
Pubmed
Borsig,
Antimetastatic activities of modified heparins: selectin inhibition by heparin attenuates metastasis.
2007,
Pubmed
Borsig,
Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis.
2001,
Pubmed
Borsig,
Selectin blocking activity of a fucosylated chondroitin sulfate glycosaminoglycan from sea cucumber. Effect on tumor metastasis and neutrophil recruitment.
2007,
Pubmed
,
Echinobase
Chen,
Inhibition of human CD24 binding to platelet-bound P-selectin by monoclonal antibody.
2004,
Pubmed
Chen,
P-selectin mediates adhesion of leukocytes, platelets, and cancer cells in inflammation, thrombosis, and cancer growth and metastasis.
2006,
Pubmed
Das Thakur,
Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance.
2013,
Pubmed
Erpenbeck,
Deadly allies: the fatal interplay between platelets and metastasizing cancer cells.
2010,
Pubmed
Felding-Habermann,
Role of beta3 integrins in melanoma cell adhesion to activated platelets under flow.
1996,
Pubmed
Ferroni,
Prognostic value of soluble P-selectin levels in colorectal cancer.
2004,
Pubmed
Gao,
Chemically modified heparin inhibits the in vitro adhesion of nonsmall cell lung cancer cells to P-selectin.
2006,
Pubmed
Garcia,
P-selectin mediates metastatic progression through binding to sulfatides on tumor cells.
2007,
Pubmed
Gay,
Contribution of platelets to tumour metastasis.
2011,
Pubmed
Golubovskaya,
Focal adhesion kinase as a cancer therapy target.
2010,
Pubmed
Hostettler,
P-selectin- and heparanase-dependent antimetastatic activity of non-anticoagulant heparins.
2007,
Pubmed
Kim,
P-selectin deficiency attenuates tumor growth and metastasis.
1998,
Pubmed
Koedam,
P-selectin, a granule membrane protein of platelets and endothelial cells, follows the regulated secretory pathway in AtT-20 cells.
1992,
Pubmed
Kozlowski,
Ascidian dermatan sulfates attenuate metastasis, inflammation and thrombosis by inhibition of P-selectin.
2011,
Pubmed
Läubli,
L-selectin facilitation of metastasis involves temporal induction of Fut7-dependent ligands at sites of tumor cell arrest.
2006,
Pubmed
Läubli,
Selectins as mediators of lung metastasis.
2010,
Pubmed
Li,
Study on anti-metastasis of heparin derivatives as ligand antagonist of p-selectin.
2010,
Pubmed
Liang,
Retinoic acid signaling plays a restrictive role in zebrafish primitive myelopoiesis.
2012,
Pubmed
Ludwig,
P-selectin: a common therapeutic target for cardiovascular disorders, inflammation and tumour metastasis.
2007,
Pubmed
Ma,
Heparan sulfate-like proteoglycans mediate adhesion of human malignant melanoma A375 cells to P-selectin under flow.
2000,
Pubmed
McDermott,
Overexpression of MUC1 reconfigures the binding properties of tumor cells.
2001,
Pubmed
Mervic,
Time course and pattern of metastasis of cutaneous melanoma differ between men and women.
2012,
Pubmed
Mi,
Inhibitory effects of chemically modified heparin on the P-selectin-mediated adhesion of breast cancer cells in vitro.
2009,
Pubmed
Mitra,
Integrin-regulated FAK-Src signaling in normal and cancer cells.
2006,
Pubmed
Qi,
P-selectin-mediated platelet adhesion promotes the metastasis of murine melanoma cells.
2014,
Pubmed
Raman,
Single-molecule binding of CD44 to fibrin versus P-selectin predicts their distinct shear-dependent interactions in cancer.
2011,
Pubmed
Reyes-Reyes,
Cell-surface nucleolin is a signal transducing P-selectin binding protein for human colon carcinoma cells.
2008,
Pubmed
Reyes-Reyes,
P-selectin activates integrin-mediated colon carcinoma cell adhesion to fibronectin.
2006,
Pubmed
Rouhi,
Hypoxia-induced metastasis model in embryonic zebrafish.
2010,
Pubmed
Sasisekharan,
Roles of heparan-sulphate glycosaminoglycans in cancer.
2002,
Pubmed
Schlesinger,
The role of VLA-4 binding for experimental melanoma metastasis and its inhibition by heparin.
2014,
Pubmed
Shibue,
Integrin beta1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs.
2009,
Pubmed
Shin,
Integrin trafficking and tumor progression.
2012,
Pubmed
Stevenson,
Heparin attenuates metastasis mainly due to inhibition of P- and L-selectin, but non-anticoagulant heparins can have additional effects.
2007,
Pubmed
Stone,
P-selectin mediates adhesion of platelets to neuroblastoma and small cell lung cancer.
1993,
Pubmed
Tsuruo,
Platelet aggregation in the formation of tumor metastasis.
2008,
Pubmed
Varki,
P-selectin, carcinoma metastasis and heparin: novel mechanistic connections with therapeutic implications.
2001,
Pubmed
Varki,
Heparin inhibition of selectin-mediated interactions during the hematogenous phase of carcinoma metastasis: rationale for clinical studies in humans.
2002,
Pubmed
Wei,
Modified heparin inhibits P-selectin-mediated cell adhesion of human colon carcinoma cells to immobilized platelets under dynamic flow conditions.
2004,
Pubmed
Xu,
Cloning and functional characterization of recombinant equine P-selectin.
2007,
Pubmed
Zhang,
Acidic mucopolysaccharide from Holothuria leucospilota has antitumor effect by inhibiting angiogenesis and tumor cell invasion in vivo and in vitro.
2009,
Pubmed
,
Echinobase
Zhao,
Holothurian glycosaminoglycan inhibits metastasis and thrombosis via targeting of nuclear factor-κB/tissue factor/Factor Xa pathway in melanoma B16F10 cells.
2013,
Pubmed